Saffron for mood

A real signal, smaller than the ads say.

Saffron extract is sold as a natural antidepressant. Short answer: in pooled placebo-controlled trials, people with mild-to-moderate depression rated their own symptoms lower on saffron, and in eight small head-to-head trials it did about as well as an SSRI with fewer side effects. But clinician-rated scores showed no difference from placebo, and a careful trial in healthy people with low mood found nothing. If you are on an antidepressant, talk to your prescriber before changing anything. If you are in crisis in the US, call or text 988.

How the evidence flows

Each claim (middle), the studies that tested it (left) — green found it, red found nothing — and the grade they add up to (right). Drawn from the same records as the grades below. Tap to open full size.

Saffron for mood · evidence checked 2026-10-28

What the research shows

Grades are calculated from the studies listed, by fixed rules.

Saffron lowers depression scores people rate themselvesEstablished
Two pooled analyses of placebo-controlled trials agree: people with mild-to-moderate depression scored lower on self-rated depression scales on saffron. The trials were small, mostly from one country, and differed widely in their results, so the size of the effect is uncertain.
- Pooled analysis of randomized trials, 1,769 people (2026) — primary outcome: improved. Funder not checked.
- Pooled analysis of randomized trials, size not stated (2019) — primary outcome: improved. Funder not checked.
Saffron works as well as an antidepressantEarly evidence
In eight small head-to-head trials, depression and anxiety fell about as much on saffron as on an SSRI, with fewer side effects — fewer, not none. Small trials can miss a real difference, and none was in severe depression. Do not stop or swap a prescribed antidepressant without your prescriber.
- Pooled analysis of randomized trials (against usual care, not a placebo), size not stated (2025) — primary outcome: improved. Funder not checked.
- Pooled analysis of randomized trials, size not stated (2019) — secondary outcome: improved. Funder not checked.
Saffron lowers depression as a clinician rates itTested — no effect found
The largest pooled analysis found no difference from placebo on the Hamilton scale, the one a clinician scores in an interview. Its authors say that gap is why better trials are needed.
- Pooled analysis of randomized trials, 1,769 people (2026) — primary outcome: no difference from placebo. Funder not checked.
Saffron lifts low mood in people who are not depressedTested — no effect found
A six-week placebo-controlled trial in healthy adults with low mood, fatigue or anxiety found no difference in those symptoms. A broader self-rated mental-health score did rise, which the authors say needs repeating.
- Double-blind randomized trial, 51 people, 6 weeks (2025) — primary outcome: no difference from placebo. Funded by mixed sources.
SaffronCo fixes all four steps of low mood — “gut conversion, production, regulation and cortisol”No real evidence
The ad said
“Most mood products fix one thing. Low mood usually hits all four steps at once: gut conversion, production, regulation and cortisol. The 2-minute quiz shows which of yours are running low.”
SaffronCo · Facebook ad, seen Oct 2026
We found no study of SaffronCo, and no trial that measured those four “steps”. Its ad also calls saffron “effective as antidepressants” with “no side effects”: the head-to-head trials above found similar results and fewer side effects in small studies, not none.